Brain Data Privacy Act MindShield Passes in EU: Thought Data Classified as Highest-Level Personal Information
EU Parliament passes brain data privacy act MindShield with absolute majority, classifying brainwave, neural signal, and thought pattern data as highest-level personal information, with unauthorized brain data collection facing fines up to 4% of annual revenue.
When Thoughts Are No Longer Only Yours
The EU Parliament today voted 467 in favor, 89 against, 34 abstaining to formally pass the brain data privacy act MindShield — the world's first legislation specifically protecting brain data. Brainwave data, neural signal patterns, and derived thought patterns, emotional states, and cognitive tendencies are classified as "special category personal information" with protection equal to genetic data.
MindShield's backdrop is the rapid proliferation of brain-computer interface (BCI) technology. From consumer EEG headsets to medical neural implants, over 20 million people worldwide use some form of BCI device. While providing convenience, these devices continuously collect brain activity data — potentially revealing emotional states, attention tendencies, and even subconscious preferences.
Core Provisions
MindShield includes: informed consent requirements with 72-hour deletion upon revocation; data minimization principles limiting collection to functionally necessary scope; prohibition of brain data commercial trade with fines up to 4% of annual revenue; neuromiscrimination bans preventing employers, insurers, and educational institutions from requiring brain data; and transparency requirements for AI systems using brain data.
Industry Reaction
BCI manufacturers Neuralink and Synchron support basic principles but question implementation details. Digital rights group Access Now called MindShield "one of the most important privacy legislations of the digital age." The advertising industry strongly opposed the prohibition on brain data for targeted advertising.
Global Impact
Like GDPR, MindShield applies to any company providing BCI products or services to EU citizens regardless of headquarters location. Several US senators have announced plans to introduce similar legislation.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.